PARAGRAPH IV CERTIFICATIONS are how generic companies expedite the launch of an ANDA for a generic competitor to an expiring patent of a brand drug that is bioequivalent to the innovator drug. Here is a useful primer of this complex arena. ”
”
http://lnkd.in/ddwrqrE
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022